- Report
- October 2024
- 196 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- April 2024
- 137 Pages
Global
From €2864EUR$2,999USD£2,395GBP
- Report
- September 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- May 2022
- 347 Pages
Global
From €4250EUR$4,450USD£3,554GBP
- Report
- February 2024
- 112 Pages
Global
From €3500EUR$3,926USD£3,029GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£759GBP
- Report
- March 2021
- 268 Pages
Global
From €3545EUR$3,712USD£2,965GBP
The COPD and Asthma Device market is a subset of the larger Respiratory Device market. It includes devices used to diagnose, monitor, and treat chronic obstructive pulmonary disease (COPD) and asthma. These devices range from inhalers and nebulizers to pulse oximeters and spirometers. Inhalers are used to deliver medication directly to the lungs, while nebulizers are used to convert liquid medication into a mist that can be inhaled. Pulse oximeters measure oxygen levels in the blood, while spirometers measure lung capacity.
The COPD and Asthma Device market is driven by the increasing prevalence of COPD and asthma, as well as technological advancements in the field. Companies in this market include Philips, ResMed, Fisher & Paykel, and Masimo. Show Less Read more
